Healthcare Dec 31, 2020 10:20 AM (GMT+8) · EqualOcean
On December 31, the joint prevention and control mechanism of the State Council released that Sinopharm China Bio new crown inactivated vaccine has been approved by the State Food and Drug Administration for conditional listing. Yesterday's report showed that the protection rate of Sinopharm Xinguan vaccine was 79.34%. Affected by the news, Sinopharm shares rose by 7%.